Inflammatory Bowel Disease (IBD) research hub
3 indexed studies · 1 currently recruiting
- ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
Investigating the safety, feasibility, and optimal dose of fluorescently labeled Adalimumab-680LT for visualizing drug targeting in Inflammatory Bowel Diseases.
This study is looking at a new way to see how a medicine called adalimumab works in people with Inflammatory Bowel Disease (IBD). We're using a special version of the medicine that glows, so doctors can track it and understand its effects better.
Netherlands - ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
Investigating the safety, feasibility, and optimal dose of risankizumab-800CW for visualizing drug targeting in Inflammatory Bowel Disease
This study is looking at a new way to see how a medicine called Skyrizi works in people with Inflammatory Bowel Disease (IBD). It's checking if the medicine is safe, how much to give, and how well it helps doctors see inflammation inside the body.
Netherlands - recruitingNA
Elemental 028 Extra Case Studies
This study looks at a new version of a special liquid diet called Elemental 028 Extra. It's for people with severe gut problems or allergies who need this type of food. We want to see how well people like it, if they can stick to it, and if it causes any tummy issues.
United Kingdom